|
MechanismNMDA receptor antagonists |
|
|
|
|
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with PHARMOS, a.s.
0 Patents (Medical) associated with PHARMOS, a.s.
100 Deals associated with PHARMOS, a.s.
100 Translational Medicine associated with PHARMOS, a.s.